Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study
Titel:
Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study
Auteur:
van Ramshorst, Mette S. van Werkhoven, Erik Mandjes, Ingrid A.M. Schot, Margaret Wesseling, Jelle Vrancken Peeters, Marie-Jeanne T.F.D. Meerum Terwogt, Jetske M. Bos, Monique E.M. Oosterkamp, Hendrika M. Rodenhuis, Sjoerd Linn, Sabine C. Sonke, Gabe S.